Filing Details

Accession Number:
0001209191-15-085462
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-15 21:00:38
Reporting Period:
2015-12-11
Filing Date:
2015-12-15
Accepted Time:
2015-12-15 21:00:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411158 Anacor Pharmaceuticals Inc. ANAC Pharmaceutical Preparations (2834) 251854385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202769 L Paul Berns C/O Anacor Pharmaceuticals, Inc.
1020 East Meadow Circle
Palo Alto CA 94303
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-11 14,000 $5.20 268,760 No 4 M Direct
Common Stock Acquisiton 2015-12-11 6,000 $21.21 274,760 No 4 M Direct
Common Stock Disposition 2015-12-11 590 $115.52 274,170 No 4 S Direct
Common Stock Disposition 2015-12-11 10,732 $117.04 263,438 No 4 S Direct
Common Stock Disposition 2015-12-11 8,178 $117.60 255,260 No 4 S Direct
Common Stock Disposition 2015-12-11 500 $118.59 254,760 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-12-11 14,000 $0.00 14,000 $5.20
Common Stock Stock Option (right to buy) Disposition 2015-12-11 6,000 $0.00 6,000 $21.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-05-30 No 4 M Direct
294,000 2024-03-21 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person for tax and estate planning purposes.
  2. The price reported in Column 4 is a weighted average price.
  3. These shares were sold in multiple transactions at prices ranging from $115.24 to $115.75, inclusive.
  4. These shares were sold in multiple transactions at prices ranging from $116.25 to $117.24, inclusive.
  5. These shares were sold in multiple transactions at prices ranging from $117.25 to $118.20, inclusive.
  6. These shares were sold in multiple transactions at prices ranging from $118.36 to $118.87, inclusive.
  7. This option is fully vested and exercisable.
  8. The award is subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting each month thereafter. The Vesting Commencement Date was March 18, 2014.